Vow ASA
4.3.2025 20:41:52 CET | Globenewswire | Press release
Vow ASA: Grant of synthetic options
Vow ASA: Grant of synthetic options
Oslo, 4 March 2025: Reference is made to the exchange announcement published by Vow ASA (the "Company") on 5 February 2025 regarding the appointment of Gunnar Pedersen as its new Chief Executive Officer, effective no later than 1 August 2025. Mr. Pedersen has today been granted synthetic options equivalent to a value of NOK 1,000,000. The options are to be cash settled, subject to a 3-year term, a strike price of NOK 4 and customary terms and conditions.
This information is subject to the disclosure requirements pursuant to section 4.2.4(1) no. 1 of the Oslo Stock Exchange's issuer rules.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Rocket Lab Corporation28.3.2026 11:39:53 CET | Press release
Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom